Corrigendum: CIRCLE-seq: A highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets (Nature Methods (2017) 14 (607-614) DOI: 10.1038/nmeth.4278);CIRCLE-seq: A highly sensitive in vitro screen for genome-wide CRISPR-Cas9 nuclease off-targets

Nature Methods

Volumn 14, Issue 6, 2017, Pages 607-614

  Tsai, Shengdar Q ^a,b,d   Nguyen, Nhu T ^a   Malagon Lopez, Jose ^a,b,c   Topkar, Ved V ^a   Aryee, Martin J ^a,b,c   Joung, J Keith ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; NUCLEASE; DEOXYRIBONUCLEASE;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRISPR CAS SYSTEM; DNA FRAGMENTATION; DNA STRUCTURE; GENE FREQUENCY; GENE MUTATION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC DIFFERENCE; GENETIC VARIABILITY; GENETIC VARIATION; GENOME ANALYSIS; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; K-562 CELL LINE; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REPRODUCIBILITY; SINGLE NUCLEOTIDE POLYMORPHISM; CHROMOSOMAL MAPPING; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; DNA SEQUENCE; GENETICS; GENOME; PROCEDURES; SENSITIVITY AND SPECIFICITY;

CHROMOSOME MAPPING; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; CRISPR-CAS SYSTEMS; DEOXYRIBONUCLEASES; GENOME; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA;

EID: 85018272560     PISSN: 15487091     EISSN: 15487105     Source Type: Journal    
DOI: 10.1038/nmeth0518-394c     Document Type: Erratum

References (43)

1. Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823 (2013).
2. Hwang, W.Y. et al. Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat. Biotechnol. 31, 227-229 (2013).
3. Jinek, M. et al. RNA-programmed genome editing in human cells. eLife 2, e00471 (2013).
4. Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823-826 (2013).
5. Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816-821 (2012).
6. Doudna, J.A., Charpentier, E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346, 1258096 (2014).
7. Bolukbasi, M.F., Gupta, A., Wolfe, S.A. Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery. Nat. Methods 13, 41-50 (2016).
8. Mali, P., Esvelt, K.M., Church, G.M. Cas9 as a versatile tool for engineering biology. Nat. Methods 10, 957-963 (2013).
9. Sander, J.D., Joung, J.K. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat. Biotechnol. 32, 347-355 (2014).
10. Maeder, M.L., Gersbach, C.A. Genome-editing technologies for gene and cell therapy. Mol. Ther. 24, 430-446 (2016).
11. Lin, J., Musunuru, K. Genome engineering tools for building cellular models of disease. FEBS J. 283, 3222-3231 (2016).
12. Hsu, P.D., Lander, E.S., Zhang, F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157, 1262-1278 (2014).
13. Brandsma, I., Gent, D.C. Pathway choice in DNA double strand break repair: Observations of a balancing act. Genome Integr. 3, 9 (2012).
14. Symington, L.S., Gautier, J. Double-strand break end resection and repair pathway choice. Annu. Rev. Genet. 45, 247-271 (2011).
15. Kass, E.M., Jasin, M. Collaboration and competition between DNA double-strand break repair pathways. FEBS Lett. 584, 3703-3708 (2010).
16. Wyman, C., Kanaar, R. DNA double-strand break repair: All's well that ends well. Annu. Rev. Genet. 40, 363-383 (2006).
17. Rouet, P., Smih, F., Jasin, M. Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease. Mol. Cell. Biol. 14, 8096-8106 (1994).
18. Sternberg, S.H., LaFrance, B., Kaplan, M., Doudna, J.A. Conformational control of DNA target cleavage by CRISPR-Cas9. Nature 527, 110-113 (2015).
19. Kiani, S. et al. Cas9 gRNA engineering for genome editing, activation and repression. Nat. Methods 12, 1051-1054 (2015).
20. Dahlman, J.E. et al. Orthogonal gene knockout and activation with a catalytically active Cas9 nuclease. Nat. Biotechnol. 33, 1159-1161 (2015).
21. Fu, Y., Sander, J.D., Reyon, D., Cascio, V.M., Joung, J.K. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat. Biotechnol. 32, 279-284 (2014).
22. Anders, C., Niewoehner, O., Duerst, A., Jinek, M. Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature 513, 569-573 (2014).
23. Shah, S.A., Erdmann, S., Mojica, F.J.M., Garrett, R.A. Protospacer recognition motifs: Mixed identities and functional diversity. RNA Biol. 10, 891-899 (2013).
24. Tsai, S.Q., Joung, J.K. Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases. Nat. Rev. Genet. 17, 300-312 (2016).
25. Gori, J.L. et al. Delivery and specificity of CRISPR-Cas9 genome editing technologies for human gene therapy. Hum. Gene Ther. 26, 443-451 (2015).
26. Cox, D.B.T., Platt, R.J., Zhang, F. Therapeutic genome editing: Prospects and challenges. Nat. Med. 21, 121-131 (2015).
27. Gabriel, R. et al. An unbiased genome-wide analysis of zinc-finger nuclease specificity. Nat. Biotechnol. 29, 816-823 (2011).
28. Ran, F.A. et al. In vivo genome editing using Staphylococcus aureus Cas9. Nature 520, 186-191 (2015).
29. Tsai, S.Q. et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat. Biotechnol. 33, 187-197 (2015).
30. Frock, R.L. et al. Genome-wide detection of DNA double-stranded breaks induced by engineered nucleases. Nat. Biotechnol. 33, 179-186 (2015).
31. Crosetto, N. et al. Nucleotide-resolution DNA double-strand break mapping by next-generation sequencing. Nat. Methods 10, 361-365 (2013).
32. Pattanayak, V. et al. High-throughput profiling of off-target DNA cleavage reveals RNA-programmed Cas9 nuclease specificity. Nat. Biotechnol. 31, 839-843 (2013).
33. Kim, D. et al. Digenome-seq: Genome-wide profiling of CRISPR-Cas9 off-target effects in human cells. Nat. Methods 12, 237-243, 1 p following 243 (2015).
34. Kim, D., Kim, S., Kim, S., Park, J., Kim, J.-S. Genome-wide target specificities of CRISPR-Cas9 nucleases revealed by multiplex Digenome-seq. Genome Res. 26, 406-415 (2016).
35. Yang, L. et al. Targeted and genome-wide sequencing reveal single nucleotide variations impacting specificity of Cas9 in human stem cells. Nat. Commun. 5, 5507 (2014).
36. 1000 Genomes Project Consortium. A global reference for human genetic variation. Nature 526, 68-74 (2015).
37. Sherry, S.T. et al. dbSNP: The NCBI database of genetic variation. Nucleic Acids Res. 29, 308-311 (2001).
38. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
39. Kleinstiver, B.P. et al. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529, 490-495 (2016).
40. Tsai, S.Q., Joung, J.K. CIRCLE-seq protocol. Protocol Exchange. http://dx.doi.org/10.1038/protex.2017.047 (2017).
41. Li, H., Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589-595 (2010).
42. Li, H. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics 27, 2987-2993 (2011).
43. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).